🇺🇸 FDA
Patent

US 10675341

Parenteral norovirus vaccine formulations

granted A61KA61K2039/5258A61K2039/545

Quick answer

US patent 10675341 (Parenteral norovirus vaccine formulations) held by Takeda Vaccines, Inc. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/5258, A61K2039/545, A61K2039/55505, A61K2039/55572